These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

417 related articles for article (PubMed ID: 30283822)

  • 61. CBD Retailers in NC Promote CBD Online to Treat Pain Violating FDA Rules About Medical Claims and Offer Low-CBD/High-Price Products.
    Amann L; Kruse E; Lazard AJ; Reboussin BA; Wagoner KG; Romero-Sandoval EA
    J Pain Res; 2022; 15():3847-3858. PubMed ID: 36514481
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Cannabinoid Content and Label Accuracy of Various Hemp-Derived Haircare, Cosmetic, and Edible Products Available at Retail Stores and Online in the United States.
    Dowd AN; Zamarripa CA; Sholler DJ; Cone EJ; Murphy TP; ElSohly M; ElSohly K; Gul W; Shahzadi I; Mullen LD; Winecker RE; Flegel RR; Vandrey R; Spindle TR
    Cannabis Cannabinoid Res; 2024 Jul; ():. PubMed ID: 39029473
    [No Abstract]   [Full Text] [Related]  

  • 63. Regulating for Safety: Cannabidiol Dose in Food: A Review.
    Nyland CR; Moyer DC
    J Food Prot; 2022 Sep; 85(9):1355-1369. PubMed ID: 35687745
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Advances and Challenges of Cannabidiol as an Anti-Seizure Strategy: Preclinical Evidence.
    Zavala-Tecuapetla C; Luna-Munguia H; López-Meraz ML; Cuellar-Herrera M
    Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555823
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Cannabinoids in treatment-resistant epilepsy: A review.
    O'Connell BK; Gloss D; Devinsky O
    Epilepsy Behav; 2017 May; 70(Pt B):341-348. PubMed ID: 28188044
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Cannabis, a Miracle Drug with Polyvalent Therapeutic Utility: Preclinical and Clinical-Based Evidence.
    Verma R; Hoda F; Arshad M; Iqubal A; Siddiqui AN; Khan MA; Haque SE; Akhtar M; Najmi AK
    Med Cannabis Cannabinoids; 2021 Jun; 4(1):43-60. PubMed ID: 34676349
    [No Abstract]   [Full Text] [Related]  

  • 67. Current Status and Prospects for Cannabidiol Preparations as New Therapeutic Agents.
    Fasinu PS; Phillips S; ElSohly MA; Walker LA
    Pharmacotherapy; 2016 Jul; 36(7):781-96. PubMed ID: 27285147
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Cannabidiol for Pain Treatment: Focus on Pharmacology and Mechanism of Action.
    Mlost J; Bryk M; Starowicz K
    Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33238607
    [TBL] [Abstract][Full Text] [Related]  

  • 69. In Vitro and In Vivo Anti-Inflammatory Effects of Cannabidiol Isolated from Novel Hemp (
    Kim JH; Hong M; Han JH; Ryu BR; Lim YS; Lim JD; Kim CH; Lee SU; Kwon TH
    Molecules; 2023 Sep; 28(18):. PubMed ID: 37764215
    [No Abstract]   [Full Text] [Related]  

  • 70. New Methods for the Comprehensive Analysis of Bioactive Compounds in
    Pellati F; Brighenti V; Sperlea J; Marchetti L; Bertelli D; Benvenuti S
    Molecules; 2018 Oct; 23(10):. PubMed ID: 30322208
    [No Abstract]   [Full Text] [Related]  

  • 71. Medical cannabis and cannabidiol: A new harvest for Malawi.
    Bandawe G
    Malawi Med J; 2022 Jun; 34(2):138-142. PubMed ID: 35991815
    [TBL] [Abstract][Full Text] [Related]  

  • 72.
    Pellati F; Borgonetti V; Brighenti V; Biagi M; Benvenuti S; Corsi L
    Biomed Res Int; 2018; 2018():1691428. PubMed ID: 30627539
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Pharmacology of Medical Cannabis.
    Amin MR; Ali DW
    Adv Exp Med Biol; 2019; 1162():151-165. PubMed ID: 31332738
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hemp-based psychoactive use and risk among young adults: Trend theory, policy, and regulation beyond legality.
    Pawson M; Kelly BC
    Int J Drug Policy; 2024 Aug; 130():104523. PubMed ID: 39024688
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Anti-Cancer and Anti-Proliferative Potential of Cannabidiol: A Cellular and Molecular Perspective.
    Mashabela MD; Kappo AP
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891847
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Cannabidiol (CBD) as a novel treatment in the early phases of psychosis.
    Chesney E; Oliver D; McGuire P
    Psychopharmacology (Berl); 2022 May; 239(5):1179-1190. PubMed ID: 34255100
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Abuse potential assessment of cannabidiol (CBD) in recreational polydrug users: A randomized, double-blind, controlled trial.
    Schoedel KA; Szeto I; Setnik B; Sellers EM; Levy-Cooperman N; Mills C; Etges T; Sommerville K
    Epilepsy Behav; 2018 Nov; 88():162-171. PubMed ID: 30286443
    [TBL] [Abstract][Full Text] [Related]  

  • 78. First systematic evaluation of the potency of Cannabis sativa plants grown in Albania.
    Bruci Z; Papoutsis I; Athanaselis S; Nikolaou P; Pazari E; Spiliopoulou C; Vyshka G
    Forensic Sci Int; 2012 Oct; 222(1-3):40-6. PubMed ID: 22608266
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Cannabidiol (CBD): Perspectives from Pinterest.
    Merten JW; Gordon BT; King JL; Pappas C
    Subst Use Misuse; 2020; 55(13):2213-2220. PubMed ID: 32715862
    [TBL] [Abstract][Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.